Tympanic cavity ultraphonophoresis in cases of preserving integrity of tympanic membrane

Author:

Krotov S. Yu., ,Ignat’ev Yu. T.,Krotov Yu. A., ,

Abstract

One of the most common treatments for the middle ear disorders is the injection of medications into the tympanic cavity through the acoustic meatus. This method has proven itself in treatment of the perforated forms of otitis. In cases of preserving the integrity of the tympanic membrane, its efficacy is arguable due to the impossibility of drug direct penetration via the membrane and contact with the mucous membrane. To increase the permeability of the tympanum, the authors used endaural phonophoresis of drugs. The drug penetration into the tympanum was confirmed by multispiral computed tomography (MSCT) of the temporal bones before and after contrasted ultraphonophoresis with tissue contrast. A 5% solution of potassium iodide was used as a contrast substance, as well as a solution of dexamethasone, which served as an intermediate medium in patients with external otitis and a chronic secretory otitis media. The mechanism of penetration was associated with the primary accumulation of the drug in the layers of the tympanic and adjacent mucous membranes with further dissemination into the deeper parts of the tympanic cavity. An additional confirmation of this is the reaction of the mucous membrane of the tympanic cavity, the mastoid process and the airiness restoration during endaural phonophoresis with dexamethasone. Ultraphonophoresis of drugs through the imperforated eardrum can be used in the conservative treatment of protracted forms of secretory otitis media.

Publisher

LLC Polyforum Group

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3